Interaction of metal oxide nanoparticles with lung surfactant protein A
- PMID: 21056657
- DOI: 10.1016/j.ejpb.2010.10.013
Interaction of metal oxide nanoparticles with lung surfactant protein A
Abstract
The alveolar lining fluid (ALF) covering the respiratory epithelium of the deep lung is the first biological barrier encountered by nanoparticles after inhalation. We here report for the first time significant differences for metal oxide nanoparticles to the binding of surfactant protein A (SP-A), the predominant protein component of ALF. SP-A is a physiologically most relevant protein and provides important biological signals. Also, it is involved in the lung's immune defence, controlling e.g. particle binding, uptake or transcytosis by epithelial cells and macrophages. In our study, we could prove different particle-protein interaction for eight different nanoparticles, whereas particles of the same bulk material revealed different adsorption patterns. In contrast to other proteins as bovine serum albumin (BSA), SP-A does not seem to significantly deagglomerate large agglomerates of particles, indicating different adsorption mechanisms as in the well-investigated model protein BSA. These findings may have important consequences for biological fate and toxicological effects of inhaled nanomaterials.
Copyright © 2010 Elsevier B.V. All rights reserved.
Similar articles
-
Dispersion characteristics of various metal oxide secondary nanoparticles in culture medium for in vitro toxicology assessment.Toxicol In Vitro. 2010 Apr;24(3):1009-18. doi: 10.1016/j.tiv.2009.12.006. Epub 2009 Dec 13. Toxicol In Vitro. 2010. PMID: 20006982
-
Change in agglomeration status and toxicokinetic fate of various nanoparticles in vivo following lung exposure in rats.Inhal Toxicol. 2012 Oct;24(12):821-30. doi: 10.3109/08958378.2012.721097. Inhal Toxicol. 2012. PMID: 23033995
-
Differential plasma protein binding to metal oxide nanoparticles.Nanotechnology. 2009 Nov 11;20(45):455101. doi: 10.1088/0957-4484/20/45/455101. Epub 2009 Oct 13. Nanotechnology. 2009. PMID: 19822937
-
Interaction of nanoparticles with the pulmonary surfactant system.Inhal Toxicol. 2009 Jul;21 Suppl 1:97-103. doi: 10.1080/08958370903005744. Inhal Toxicol. 2009. PMID: 19558240 Review.
-
Particle characteristics responsible for effects on human lung epithelial cells.Res Rep Health Eff Inst. 2002 Dec;(110):1-65; discussion 67-76. Res Rep Health Eff Inst. 2002. PMID: 12578113 Review.
Cited by
-
Aerosol-Cell Exposure System Applied to Semi-Adherent Cells for Aerosolization of Lung Surfactant and Nanoparticles Followed by High Quality RNA Extraction.Nanomaterials (Basel). 2022 Apr 15;12(8):1362. doi: 10.3390/nano12081362. Nanomaterials (Basel). 2022. PMID: 35458071 Free PMC article.
-
Biocompatible micro-sized cell culture chamber for the detection of nanoparticle-induced IL8 promoter activity on a small cell population.Nanoscale Res Lett. 2011 Aug 23;6(1):505. doi: 10.1186/1556-276X-6-505. Nanoscale Res Lett. 2011. PMID: 21861875 Free PMC article.
-
Surfactant protein A (SP-A) inhibits agglomeration and macrophage uptake of toxic amine modified nanoparticles.Nanotoxicology. 2015;9(8):952-62. doi: 10.3109/17435390.2014.992487. Nanotoxicology. 2015. PMID: 25676620 Free PMC article.
-
The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles.PLoS One. 2012;7(7):e40775. doi: 10.1371/journal.pone.0040775. Epub 2012 Jul 10. PLoS One. 2012. PMID: 22802970 Free PMC article.
-
The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery.Nanomedicine (Lond). 2016 Jan;11(1):81-100. doi: 10.2217/nnm.15.188. Epub 2015 Dec 11. Nanomedicine (Lond). 2016. PMID: 26653875 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources